ATX Study:A Study of Avastin (Bevacizumab), Tarceva (Erlotinib) and Xeloda (Capecitabine) in Patients With Locally Advanced and/or Metastatic Pancreatic Cancer
Clinical trial NCT00925769 · COMPLETED
Trial details
- NCT number
- NCT00925769
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-01-01
- Primary completion
- 2013-12-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.